News and Updates

Deerfield Management Closes Over $600 Million Healthcare Venture Fund

Deerfield's Healthcare Innovations Fund III will invest in promising therapeutics, improvements to healthcare delivery, and paradigm-shifting technologies

Deerfield Management Welcomes Mark Michalski, M.D., as Chief Information Officer

Michalski will lead Deerfield's efforts to advance healthcare via excellence in software and artificial intelligence

Deerfield Management Supports Brookdale Senior Living

Deerfield Management Announces Collaboration with QIA as Part of its Fund of Funds VC Program and the Opening of a Regional Office in Doha

The University of Chicago and Deerfield Management Launch Hyde Park Discovery to Accelerate Translation of Research Into Life-Saving Treatments

Deerfield Management commits up to $130 million to support UChicago drug discovery and development

Deerfield Foundation Awards $1.5 Million to Improve Health, Accelerate Innovation, and Promote Equity

Fourteen organizations in seven countries will receive support for innovative projects focused on advancing children's health, ranging from improved treatments to sweeping public health initiatives

Deerfield Management and the University of North Carolina Eshelman School of Pharmacy Launch Biotherapeutics Certificate Program Bridging Academia and Industry

Inaugural "Molecules to Market" cohort to commence coursework in February 2025. Program content developed and taught by industry professionals at Deerfield in collaboration with academic experts at UNC-Chapel Hill.

Deerfield Management launches joint venture with Horizon Blue Cross Blue Shield of New Jersey

Elion Therapeutics Closes $81 Million Series B Funding Round Led by Deerfield Management and AMR Action Fund

Funds to support advancement of SF001, a next-generation polyene antifungal designed for reduced toxicity

Deerfield Management Welcomes Frank Nestle, MD, FMedSci, as Partner and Chief Executive Officer of Therapeutic Discovery and Development

• Frank Nestle, MD, FMedSci joins Deerfield from previous position as Global Head of Research and Chief Scientific Officer at Sanofi • Nestle will lead therapeutic discovery and development as Partner and Chief Executive Officer of Deerfield Discovery and Development (“3DC”)

Deerfield Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of American Society of Hematology (ASH) Peter Steelman Scholar Award

Deerfield names two healthcare leaders as latest recipients of the ASH Peter Steelman Scholar Award

Genscience and Deerfield Management Announce Nature Publication Reporting Positive Impact of Genetic Evidence to Aid Discovery of More Effective Drug Targets